319 related articles for article (PubMed ID: 18580387)
1. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.
Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD
Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387
[TBL] [Abstract][Full Text] [Related]
2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
3. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA
Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544
[TBL] [Abstract][Full Text] [Related]
6. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.
Leslie DL; Rosenheck RA
J Ment Health Policy Econ; 2003 Sep; 6(3):113-21. PubMed ID: 14646004
[TBL] [Abstract][Full Text] [Related]
7. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of the efficacy of second-generation antipsychotics.
Davis JM; Chen N; Glick ID
Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218
[TBL] [Abstract][Full Text] [Related]
9. Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications.
Sernyak MJ; Rosenheck R
Adm Policy Ment Health; 2007 Nov; 34(6):540-7. PubMed ID: 17957463
[TBL] [Abstract][Full Text] [Related]
10. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study.
Gründer G; Heinze M; Cordes J; Mühlbauer B; Juckel G; Schulz C; Rüther E; Timm J;
Lancet Psychiatry; 2016 Aug; 3(8):717-729. PubMed ID: 27265548
[TBL] [Abstract][Full Text] [Related]
11. Factors related to antipsychotic oversupply among Central Texas Veterans.
Yang M; Barner JC; Worchel J
Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
[TBL] [Abstract][Full Text] [Related]
12. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
Hudson TJ; Owen RR; Thrush CR; Armitage TL; Thapa P
J Clin Psychiatry; 2008 Jan; 69(1):74-80. PubMed ID: 18312040
[TBL] [Abstract][Full Text] [Related]
13. Facility-level factors influencing chronic heart failure care process performance in a national integrated health delivery system.
Subramanian U; Sutherland J; McCoy KD; Welke KF; Vaughn TE; Doebbeling BN
Med Care; 2007 Jan; 45(1):28-45. PubMed ID: 17279019
[TBL] [Abstract][Full Text] [Related]
14. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.
Volavka J; Citrome L
Expert Opin Pharmacother; 2009 Aug; 10(12):1917-28. PubMed ID: 19558339
[TBL] [Abstract][Full Text] [Related]
15. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
[TBL] [Abstract][Full Text] [Related]
16. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care.
Bauer MS; Biswas K; Kilbourne AM
Am J Psychiatry; 2009 Nov; 166(11):1244-50. PubMed ID: 19797436
[TBL] [Abstract][Full Text] [Related]
17. Ethnic comparisons of antipsychotic use in schizophrenia.
Wheeler A; Humberstone V; Robinson E
Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
[TBL] [Abstract][Full Text] [Related]
18. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
19. Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.
Weissman E; Jackson C; Schooler N; Goetz R; Essock S
Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):201-7. PubMed ID: 22182457
[TBL] [Abstract][Full Text] [Related]
20. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
